Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $8.94 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.74.
Market Cap
8.94T
Revenue
4.59T
Profits
199.82B
PE Ratio
44.74
Profit Margin
4.35%
Dividend Yield
0.39%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 2.49% | 2,092,001 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 603.27B | 0.72% | 7,793,070 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 452.48B | 1.07% | 4,819,291 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 396.27B | 3.51% | 6,833,628 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 311.84B | 1.50% | 7,344,785 | 65.77B |
| 6 | NVS | Novartis AG | 282.96B | 2.88% | 2,654,215 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 259.20B | 2.93% | 1,986,357 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 218.73B | -0.46% | 5,785,783 | 50.57B |
| 9 | AMGN | Amgen Inc. | 197.66B | 0.57% | 2,881,908 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 194.53B | -0.53% | 3,524,980 | 45.20B |
| 11 | ABT | Abbott Laboratories | 173.61B | -1.96% | 11,656,451 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 161.75B | -2.20% | 8,371,109 | 29.74B |
| 13 | PFE | Pfizer Inc. | 142.14B | 0.77% | 27,328,847 | 63.32B |
| 14 | CVS | CVS Health Corporation | 141.12B | 2.78% | 9,856,298 | 405.62B |
| 15 | DHR | Danaher Corporation | 125.84B | -10.99% | 28,098,194 | 25.11B |
| 16 | BMY | Bristol-Myers Squibb Company | 124.42B | 1.28% | 7,744,559 | 48.48B |
| 17 | ISRG | Intuitive Surgical, Inc. | 123.98B | -0.88% | 5,161,004 | 11.03B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 122.33B | 0.31% | 1,107,415 | 12.22B |
| 19 | SYK | Stryker Corporation | 120.60B | -1.43% | 1,412,708 | 25.27B |
| 20 | MDT | Medtronic plc | 105.41B | -1.13% | 5,840,409 | 36.36B |
| 21 | SNY | Sanofi | 105.26B | -0.52% | 2,193,534 | 54.60B |
| 22 | GSK | GSK plc | 100.85B | 1.48% | 3,901,505 | 43.29B |
| 23 | MCK | McKesson Corporation | 97.04B | -0.32% | 846,485 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 85.33B | 2.93% | 1,414,287 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 82.77B | 0.72% | 1,364,837 | 76.39B |
| 26 | CI | The Cigna Group | 76.84B | 2.31% | 1,353,890 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 68.69B | 0.45% | 529,784 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 64.20B | -1.33% | 25,009,838 | 20.61B |
| 29 | COR | Cencora, Inc. | 58.97B | -0.30% | 1,324,680 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 54.40B | 1.06% | 4,808,028 | 28.34B |
| 31 | ARGX | argenx SE | 54.26B | 3.37% | 256,581 | 4.74B |
| 32 | CAH | Cardinal Health, Inc. | 53.19B | 0.59% | 1,595,262 | 250.74B |
| 33 | MDLN | Medline Inc. | 51.35B | 0.54% | 4,953,512 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 48.68B | -0.53% | 5,571,029 | 6.30B |
| 35 | HUM | Humana Inc. | 48.55B | 1.54% | 724,972 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.58B | -2.01% | 429,122 | 4.45B |
| 37 | HLN | Haleon plc | 43.44B | -1.20% | 10,683,651 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 42.39B | -0.41% | 1,332,536 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 38.97B | 1.61% | 2,300,063 | - |
| 40 | NTRA | Natera, Inc. | 38.26B | 1.73% | 994,675 | 2.50B |
| 41 | A | Agilent Technologies, Inc. | 37.52B | 2.00% | 2,383,955 | 7.23B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 36.50B | 1.13% | 4,849,309 | 17.35B |
| 43 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.23B | -0.48% | 982,811 | 4.29B |
| 44 | WAT | Waters Corporation | 36.09B | 2.80% | 1,169,991 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 35.43B | 2.61% | 536,209 | 5.74B |
| 46 | IQV | IQVIA Holdings Inc. | 33.65B | -1.12% | 1,029,677 | 16.63B |
| 47 | RPRX | Royalty Pharma plc | 33.64B | 1.95% | 3,716,804 | 2.44B |
| 48 | ALC | Alcon Inc. | 33.52B | -3.84% | 2,187,488 | 10.63B |
| 49 | CNC | Centene Corporation | 33.38B | 2.66% | 3,340,158 | 178.33B |
| 50 | ZTS | Zoetis Inc. | 31.59B | -1.12% | 4,827,626 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.74B | -4.14% | 1,189,240 | 3.32B |
| 52 | BIIB | Biogen Inc. | 29.99B | 1.61% | 652,841 | 9.94B |
| 53 | ILMN | Illumina, Inc. | 29.13B | 4.25% | 1,365,148 | 4.39B |
| 54 | DXCM | DexCom, Inc. | 28.84B | -1.24% | 3,962,329 | 4.82B |
| 55 | RMD | ResMed Inc. | 28.24B | -1.41% | 1,112,741 | 5.54B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 28.22B | -1.26% | 3,133,293 | 20.98B |
| 57 | MTD | Mettler-Toledo International Inc. | 26.23B | 1.92% | 174,812 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.84B | -0.64% | 734,555 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 25.38B | 1.96% | 752,720 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.15B | 2.67% | 4,726,852 | 8.26M |
| 61 | MRNA | Moderna, Inc. | 23.67B | 0.29% | 4,357,387 | 2.23B |
| 62 | INSM | Insmed Incorporated | 23.54B | 1.50% | 2,447,392 | 819.56M |
| 63 | INCY | Incyte Corporation | 23.45B | 1.50% | 1,906,845 | 5.36B |
| 64 | BNTX | BioNTech SE | 23.35B | 0.18% | 696,992 | 3.23B |
| 65 | LH | Labcorp Holdings Inc. | 22.91B | -0.74% | 793,930 | 14.14B |
| 66 | DGX | Quest Diagnostics Incorporated | 22.90B | -0.39% | 691,873 | 11.28B |
| 67 | UTHR | United Therapeutics Corporation | 22.74B | 1.23% | 467,387 | 3.17B |
| 68 | STE | STERIS plc | 20.64B | -1.27% | 582,063 | 5.94B |
| 69 | VTRS | Viatris Inc. | 20.48B | 3.53% | 8,549,134 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 20.19B | 2.85% | 1,497,479 | 1.08B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 18.00B | 3.50% | 1,305,467 | 3.10B |
| 72 | GMAB | Genmab A/S | 17.36B | 1.63% | 871,699 | 3.90B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.20B | -0.89% | 1,985,688 | 8.41B |
| 74 | THC | Tenet Healthcare Corporation | 16.93B | 1.09% | 906,342 | 21.46B |
| 75 | ASND | Ascendis Pharma A/S | 16.82B | 1.37% | 549,020 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.16B | 2.09% | 1,388,507 | 579.96M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.97B | 4.42% | 810,118 | 4.44B |
| 78 | DVA | DaVita Inc. | 15.23B | 1.36% | 503,376 | 13.84B |
| 79 | MEDP | Medpace Holdings, Inc. | 15.18B | 0.71% | 281,544 | 2.68B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 15.12B | 2.92% | 2,725,357 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.11B | 1.06% | 1,820,120 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.85B | -0.81% | 2,261,084 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.61B | -0.82% | 810,007 | 8.26B |
| 84 | FMS | Fresenius Medical Care AG | 13.12B | 2.53% | 618,668 | 22.32B |
| 85 | ICLR | ICON Public Limited Company | 12.76B | 0.26% | 576,116 | 8.27B |
| 86 | ELAN | Elanco Animal Health Incorporated | 12.73B | 1.35% | 5,522,751 | 4.89B |
| 87 | ALGN | Align Technology, Inc. | 12.71B | 1.40% | 683,055 | 4.10B |
| 88 | SNN | Smith & Nephew plc | 12.65B | -0.72% | 1,133,137 | 6.16B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.61B | 2.07% | 222,279 | 1.13B |
| 90 | PEN | Penumbra, Inc. | 12.48B | -0.19% | 276,751 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.33B | 3.83% | 1,654,469 | 2.90B |
| 92 | AXSM | Axsome Therapeutics, Inc. | 12.19B | 6.91% | 993,639 | 708.24M |
| 93 | MOH | Molina Healthcare, Inc. | 11.80B | -1.38% | 9,666,696 | 43.10B |
| 94 | ABVX | ABIVAX Société Anonyme | 11.56B | 1.97% | 752,271 | 5.67M |
| 95 | BAX | Baxter International Inc. | 11.47B | 0.63% | 3,962,316 | 11.32B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.44B | 0.17% | 1,621,878 | 3.24B |
| 97 | SMMT | Summit Therapeutics Inc. | 11.36B | 8.37% | 3,925,504 | - |
| 98 | PODD | Insulet Corporation | 11.34B | -2.18% | 1,145,481 | 2.90B |
| 99 | TECH | Bio-Techne Corporation | 11.16B | -0.01% | 3,001,980 | 1.21B |
| 100 | EHC | Encompass Health Corporation | 11.12B | -0.36% | 1,067,389 | 6.07B |
| 101 | CYTK | Cytokinetics, Incorporated | 11.01B | 2.53% | 1,215,830 | 105.82M |
| 102 | CRL | Charles River Laboratories International, Inc. | 10.57B | -0.14% | 925,042 | 4.03B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.50B | 4.01% | 1,612,497 | 622.01M |
| 104 | GMED | Globus Medical, Inc. | 10.33B | 0.11% | 1,155,879 | 3.10B |
| 105 | CORT | Corcept Therapeutics Incorporated | 10.27B | 4.46% | 839,334 | 769.10M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.23B | 0.24% | 1,440,026 | 3.50B |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.04% | 428,085 | - |
| 108 | KRYS | Krystal Biotech, Inc. | 10.00B | -0.05% | 445,665 | 417.30M |
| 109 | ENSG | The Ensign Group, Inc. | 9.90B | -0.68% | 393,798 | 5.27B |
| 110 | HSIC | Henry Schein, Inc. | 9.78B | -0.39% | 1,150,410 | 13.38B |
| 111 | KYMR | Kymera Therapeutics, Inc. | 9.33B | 2.08% | 565,378 | 51.48M |
| 112 | HALO | Halozyme Therapeutics, Inc. | 9.32B | 1.96% | 1,273,027 | 1.51B |
| 113 | OSCR | Oscar Health, Inc. | 9.27B | 3.95% | 3,409,327 | 13.30B |
| 114 | BRKR | Bruker Corporation | 9.20B | 7.58% | 2,775,003 | 3.46B |
| 115 | UHS | Universal Health Services, Inc. | 9.08B | -0.48% | 543,983 | 17.76B |
| 116 | SYRE | Spyre Therapeutics, Inc. | 9.03B | 5.52% | 776,545 | - |
| 117 | GKOS | Glaukos Corporation | 8.99B | -1.52% | 476,813 | 551.35M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 8.89B | 3.01% | 580,567 | 74.06M |
| 119 | PRAX | Praxis Precision Medicines, Inc. | 8.86B | 4.41% | 229,908 | 7.46M |
| 120 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.04% | 2,734,950 | 18.07M |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 8.82B | 0.83% | 3,074,070 | 1.06B |
| 122 | ALKS | Alkermes plc | 8.81B | 2.18% | 1,179,222 | 1.56B |
| 123 | TEM | Tempus AI, Inc. | 8.80B | 1.18% | 4,755,666 | 1.36B |
| 124 | IBRX | ImmunityBio, Inc. | 8.45B | 7.60% | 8,623,912 | 140.98M |
| 125 | QGEN | Qiagen N.V. | 8.38B | 0.12% | 2,071,550 | 2.10B |
| 126 | PCVX | Vaxcyte, Inc. | 8.38B | 4.58% | 852,766 | - |
| 127 | ATR | AptarGroup, Inc. | 8.23B | -0.77% | 328,838 | 3.87B |
| 128 | HQY | HealthEquity, Inc. | 8.17B | -1.12% | 565,604 | 1.34B |
| 129 | IMVT | Immunovant, Inc. | 8.12B | -0.98% | 1,248,079 | - |
| 130 | BIO | Bio-Rad Laboratories, Inc. | 8.07B | -0.07% | 302,880 | 2.59B |
| 131 | RGEN | Repligen Corporation | 7.73B | -5.84% | 2,144,924 | 763.34M |
| 132 | TGTX | TG Therapeutics, Inc. | 7.65B | -0.02% | 1,489,681 | 700.35M |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.58B | 0.09% | 9,755,070 | 2.37B |
| 134 | AVTR | Avantor, Inc. | 7.50B | 3.10% | 11,084,936 | 6.55B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.31B | 1.91% | 520,699 | 217.17M |
| 136 | PACS | PACS Group, Inc. | 7.21B | 1.86% | 863,976 | 5.43B |
| 137 | LQDA | Liquidia Corporation | 7.19B | 4.94% | 1,160,971 | 288.07M |
| 138 | MIRM | Mirum Pharmaceuticals, Inc. | 7.14B | 0.37% | 619,528 | 569.61M |
| 139 | LNTH | Lantheus Holdings, Inc. | 7.03B | 3.40% | 901,499 | 1.55B |
| 140 | COGT | Cogent Biosciences, Inc. | 6.77B | 3.50% | 1,294,541 | - |
| 141 | ERAS | Erasca, Inc. | 6.73B | 2.98% | 2,677,578 | - |
| 142 | CHE | Chemed Corporation | 6.66B | -1.86% | 262,836 | 2.54B |
| 143 | GRFS | Grifols, S.A. | 6.60B | 1.84% | 501,128 | 8.58B |
| 144 | HNGE | Hinge Health, Inc. | 6.53B | -3.82% | 2,236,147 | 646.34M |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.51B | 0.63% | 1,145,977 | 827.11M |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 6.45B | 1.06% | 832,630 | 7.50M |
| 147 | BLTE | Belite Bio, Inc | 6.34B | 5.39% | 175,178 | - |
| 148 | CGON | CG Oncology, Inc. | 6.33B | 2.18% | 704,222 | 5.07M |
| 149 | SRRK | Scholar Rock Holding Corporation | 6.10B | 0.43% | 824,450 | - |
| 150 | BLLN | BillionToOne, Inc. | 6.10B | 5.91% | 561,573 | 354.54M |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 6.05B | 3.90% | 162,769 | 274.48M |
| 152 | TXG | 10x Genomics, Inc. | 5.99B | 9.21% | 2,465,300 | 638.78M |
| 153 | DFTX | Definium Therapeutics, Inc. | 5.98B | 5.33% | 1,498,500 | - |
| 154 | TFX | Teleflex Incorporated | 5.98B | 0.73% | 372,624 | 2.13B |
| 155 | TWST | Twist Bioscience Corporation | 5.97B | 9.62% | 914,156 | 409.48M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.78B | 4.67% | 621,403 | 1.34M |
| 157 | AMRX | Amneal Pharmaceuticals, Inc. | 5.77B | 3.43% | 2,210,379 | 3.05B |
| 158 | BLCO | Bausch + Lomb Corporation | 5.70B | 0.06% | 404,026 | 5.21B |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.69B | 2.85% | 585,506 | - |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.26B | 2.00% | 1,010,668 | 536.20M |
| 161 | STVN | Stevanato Group S.p.A. | 5.21B | -0.26% | 261,996 | 1.39B |
| 162 | SHC | Sotera Health Company | 4.96B | -0.11% | 2,776,755 | 1.19B |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 4.93B | 3.40% | 1,840,381 | 1.29B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.89B | 1.55% | 489,342 | 754.05M |
| 165 | RDNT | RadNet, Inc. | 4.87B | 1.96% | 459,206 | 2.14B |
| 166 | VCYT | Veracyte, Inc. | 4.75B | 3.96% | 864,533 | 541.74M |
| 167 | CRSP | CRISPR Therapeutics AG | 4.74B | 2.47% | 1,384,175 | 4.10M |
| 168 | MMED | MiniMed Group, Inc. | 4.69B | -1.30% | 1,125,513 | 3.10B |
| 169 | MANE | Veradermics, Incorporated | 4.57B | 3.25% | 513,296 | - |
| 170 | LEGN | Legend Biotech Corporation | 4.55B | 1.42% | 2,068,169 | 1.14B |
| 171 | CELC | Celcuity Inc. | 4.47B | 4.21% | 1,855,686 | - |
| 172 | CAI | Caris Life Sciences, Inc. | 4.45B | 1.09% | 3,188,795 | 907.29M |
| 173 | ALHC | Alignment Healthcare, Inc. | 4.44B | 1.90% | 3,936,313 | 4.26B |
| 174 | LFST | LifeStance Health Group, Inc. | 4.44B | 0.97% | 2,793,330 | 1.49B |
| 175 | VKTX | Viking Therapeutics, Inc. | 4.41B | 4.32% | 1,790,970 | - |
| 176 | LIVN | LivaNova PLC | 4.39B | 0.80% | 444,441 | 1.43B |
| 177 | MMSI | Merit Medical Systems, Inc. | 4.38B | -2.25% | 856,219 | 1.54B |
| 178 | NVST | Envista Holdings Corporation | 4.38B | 1.32% | 1,715,757 | 2.81B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 4.35B | 1.36% | 1,340,503 | 1.10B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | 1.98% | 604,215 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.21B | 0.63% | 1,485,438 | 10.68M |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.20B | 5.37% | 1,961,033 | 56.99M |
| 183 | WAY | Waystar Holding Corp. | 4.13B | -2.63% | 2,597,134 | 1.16B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 4.07B | 1.50% | 988,764 | 2.23B |
| 185 | ICUI | ICU Medical, Inc. | 3.97B | 0.91% | 236,752 | 2.16B |
| 186 | DYN | Dyne Therapeutics, Inc. | 3.94B | 1.62% | 1,373,717 | - |
| 187 | ALMS | Alumis Inc. | 3.83B | 7.40% | 875,472 | 8.40M |
| 188 | PBLS | Parabilis Medicines, Inc. | 3.83B | 10.00% | 326,374 | - |
| 189 | DOCS | Doximity, Inc. | 3.79B | -2.85% | 3,537,593 | 644.86M |
| 190 | ELVN | Enliven Therapeutics, Inc. | 3.79B | 5.15% | 636,622 | - |
| 191 | DNLI | Denali Therapeutics Inc. | 3.78B | 4.06% | 1,128,750 | - |
| 192 | NAMS | NewAmsterdam Pharma Company N.V. | 3.78B | 9.00% | 1,697,185 | 22.57M |
| 193 | RCUS | Arcus Biosciences, Inc. | 3.71B | 4.65% | 1,084,357 | 236.00M |
| 194 | BKD | Brookdale Senior Living Inc. | 3.63B | 1.74% | 3,728,402 | 3.00B |
| 195 | ADPT | Adaptive Biotechnologies Corporation | 3.61B | 3.29% | 3,505,219 | 295.41M |
| 196 | IRTC | iRhythm Holdings, Inc. | 3.58B | -2.13% | 369,770 | 787.85M |
| 197 | HAE | Haemonetics Corporation | 3.55B | -0.13% | 371,758 | 1.33B |
| 198 | OGN | Organon & Co. | 3.55B | 0.15% | 1,381,087 | 6.16B |
| 199 | TLX | Telix Pharmaceuticals Limited | 3.54B | 3.90% | 150,567 | 803.79M |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.53B | 2.65% | 1,370,446 | 415.62M |
| 201 | GPCR | Structure Therapeutics Inc. | 3.51B | 5.04% | 299,298 | - |
| 202 | NHC | National HealthCare Corporation | 3.48B | 1.35% | 110,827 | 1.53B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | 1.52% | 602,019 | 225.27M |
| 204 | OPCH | Option Care Health, Inc. | 3.40B | -0.37% | 1,973,387 | 5.67B |
| 205 | PRVA | Privia Health Group, Inc. | 3.32B | 0.19% | 1,154,745 | 2.25B |
| 206 | ACHC | Acadia Healthcare Company, Inc. | 3.27B | 3.43% | 2,770,700 | 3.37B |
| 207 | ITGR | Integer Holdings Corporation | 3.27B | 0.23% | 339,743 | 1.86B |
| 208 | GRAL | GRAIL, Inc. | 3.12B | 5.51% | 482,794 | 156.12M |
| 209 | WRBY | Warby Parker Inc. | 3.02B | 0.04% | 2,229,421 | 890.57M |
| 210 | RGC | Regencell Bioscience Holdings Limited | 3.00B | 18.82% | 582,148 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.89B | 1.61% | 392,843 | - |
| 212 | MBX | MBX Biosciences, Inc. | 2.87B | 0.23% | 698,406 | - |
| 213 | ESTA | Establishment Labs Holdings Inc. | 2.82B | 2.39% | 636,992 | 229.58M |
| 214 | RARE | Ultragenyx Pharmaceutical Inc. | 2.81B | 0.32% | 2,275,867 | 670.00M |
| 215 | CLDX | Celldex Therapeutics, Inc. | 2.80B | 0.68% | 1,392,017 | 865.00K |
| 216 | SUPN | Supernus Pharmaceuticals, Inc. | 2.78B | 0.95% | 450,290 | 776.83M |
| 217 | QURE | uniQure N.V. | 2.76B | 0.98% | 849,236 | 18.09M |
| 218 | XRAY | DENTSPLY SIRONA Inc. | 2.73B | 1.41% | 5,291,185 | 3.68B |
| 219 | BEAM | Beam Therapeutics Inc. | 2.72B | 3.65% | 1,854,705 | 164.01M |
| 220 | VERA | Vera Therapeutics, Inc. | 2.67B | 0.49% | 1,507,948 | - |
| 221 | KOD | Kodiak Sciences Inc. | 2.65B | 3.79% | 452,798 | - |
| 222 | ATAI | AtaiBeckley Inc. | 2.64B | -0.76% | 13,884,694 | 3.49M |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | 2.84% | 199,540 | 1.46B |
| 224 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 8.41% | 2,243,385 | - |
| 225 | IMNM | Immunome, Inc. | 2.58B | 2.80% | 781,407 | 4.02M |
| 226 | TMDX | TransMedics Group, Inc. | 2.57B | 1.12% | 762,879 | 635.89M |
| 227 | SLS | SELLAS Life Sciences Group, Inc. | 2.54B | 3.41% | 5,099,771 | - |
| 228 | PGNY | Progyny, Inc. | 2.53B | 1.48% | 873,865 | 1.29B |
| 229 | CLOV | Clover Health Investments, Corp. | 2.52B | 6.44% | 4,361,117 | 2.21B |
| 230 | TARS | Tarsus Pharmaceuticals, Inc. | 2.46B | 1.80% | 1,042,966 | 535.08M |
| 231 | IOVA | Iovance Biotherapeutics, Inc. | 2.45B | 9.16% | 20,354,161 | 285.61M |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.44B | 3.39% | 961,277 | 36.77M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | 3.03% | 456,635 | - |
| 234 | PHVS | Pharvaris N.V. | 2.41B | 2.68% | 284,213 | - |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.39B | 3.40% | 2,291,422 | 885.72M |
| 236 | KLRA | Kailera Therapeutics, Inc. | 2.39B | 2.79% | 421,824 | - |
| 237 | VCEL | Vericel Corporation | 2.36B | 0.57% | 504,374 | 292.09M |
| 238 | BHVN | Biohaven Ltd. | 2.34B | 4.37% | 1,752,546 | - |
| 239 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | -2.74% | 704,149 | 1.09B |
| 240 | NKTR | Nektar Therapeutics | 2.32B | 5.91% | 1,294,049 | 55.63M |
| 241 | ZLAB | Zai Lab Limited | 2.30B | -0.19% | 770,730 | 453.28M |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.30B | -1.06% | 197,171 | 256.28M |
| 243 | COAG | Hemab Therapeutics Holdings, Inc. | 2.25B | -2.25% | 376,163 | - |
| 244 | NUVB | Nuvation Bio Inc. | 2.24B | 2.72% | 7,423,381 | 143.05M |
| 245 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | -6.74% | 3,403,678 | 66.05M |
| 246 | HTFL | HeartFlow, Inc. | 2.19B | 3.58% | 895,965 | 191.42M |
| 247 | NEOG | Neogen Corporation | 2.16B | -0.80% | 1,605,318 | 870.56M |
| 248 | AXGN | Axogen, Inc. | 2.14B | 1.98% | 1,242,752 | 238.11M |
| 249 | URGN | UroGen Pharma Ltd. | 2.13B | 6.47% | 1,150,973 | 140.49M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.13B | 9.97% | 2,000,771 | 899.11M |
| 251 | SION | Sionna Therapeutics, Inc. | 2.13B | 3.33% | 598,140 | - |
| 252 | MESO | Mesoblast Limited | 2.13B | -1.26% | 203,794 | 65.38M |
| 253 | AVAH | Aveanna Healthcare Holdings Inc. | 2.12B | 0.52% | 1,404,175 | 2.52B |
| 254 | VRDN | Viridian Therapeutics, Inc. | 2.12B | 3.34% | 1,117,159 | 70.92M |
| 255 | SGRY | Surgery Partners, Inc. | 2.11B | 1.68% | 601,533 | 3.34B |
| 256 | AGL | agilon health, inc. | 2.10B | 3.01% | 166,459 | 5.82B |
| 257 | MD | Pediatrix Medical Group, Inc. | 2.10B | 1.67% | 609,661 | 1.93B |
| 258 | PLSE | Pulse Biosciences, Inc. | 2.09B | 4.49% | 283,813 | 751.00K |
| 259 | ADUS | Addus HomeCare Corporation | 2.07B | 1.62% | 320,547 | 1.45B |
| 260 | PVLA | Palvella Therapeutics, Inc. | 2.06B | 15.94% | 364,767 | - |
| 261 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.06B | 6.02% | 2,718,879 | -665.00K |
| 262 | KARD | Kardigan, Inc. | 2.05B | 7.06% | 229,777 | - |
| 263 | ASTH | Astrana Health, Inc. | 2.05B | 2.04% | 443,081 | 3.53B |
| 264 | ZBIO | Zenas BioPharma, Inc. | 2.04B | 5.41% | 1,634,867 | 10.00M |
| 265 | HCM | HUTCHMED (China) Limited | 2.04B | -1.24% | 33,252 | 548.51M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 2.04B | 5.84% | 259,984 | 20.00M |
| 267 | DMRA | Damora Therapeutics, Inc. | 2.03B | - | 436,638 | - |
| 268 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | 2.56% | 991,192 | 298.30M |
| 269 | SNDX | Syndax Pharmaceuticals, Inc. | 2.01B | 1.57% | 1,185,391 | 217.17M |
| 270 | GLUE | Monte Rosa Therapeutics, Inc. | 2.00B | 0.64% | 777,086 | 42.95M |
| 271 | CDNA | CareDx, Inc. | 1.99B | 0.44% | 1,135,455 | 412.82M |
| 272 | ADMA | ADMA Biologics, Inc. | 1.99B | -1.83% | 2,579,080 | 509.86M |
| 273 | PGEN | Precigen, Inc. | 1.96B | 8.28% | 4,384,642 | 31.60M |
| 274 | OCUL | Ocular Therapeutix, Inc. | 1.96B | 2.53% | 1,584,522 | 52.04M |
| 275 | GHRS | GH Research PLC | 1.95B | 2.98% | 152,193 | - |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.93B | 2.19% | 302,483 | 367.34M |
| 277 | NBTX | Nanobiotix S.A. | 1.93B | 10.33% | 131,835 | 38.27M |
| 278 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 0.72% | 96,052 | 1.20B |
| 279 | OMCL | Omnicell, Inc. | 1.90B | -7.50% | 1,579,679 | 1.23B |
| 280 | TYRA | Tyra Biosciences, Inc. | 1.89B | 2.54% | 353,205 | - |
| 281 | UFPT | UFP Technologies, Inc. | 1.89B | -0.68% | 116,827 | 608.85M |
| 282 | NEO | NeoGenomics, Inc. | 1.88B | 1.47% | 1,577,869 | 745.97M |
| 283 | NVCR | NovoCure Limited | 1.85B | 0.38% | 1,069,311 | 674.41M |
| 284 | BCAX | Bicara Therapeutics Inc. | 1.85B | 3.68% | 289,429 | - |
| 285 | GENB | Generate Biomedicines, Inc. | 1.84B | 5.96% | 603,202 | 30.30M |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | 1.57% | 2,833,476 | 204.73M |
| 287 | WGS | GeneDx Holdings Corp. | 1.83B | 1.65% | 772,643 | 442.68M |
| 288 | ABCL | AbCellera Biologics Inc. | 1.82B | 2.93% | 5,132,274 | 79.21M |
| 289 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | 1.61% | 1,852,763 | 7.47M |
| 290 | STOK | Stoke Therapeutics, Inc. | 1.79B | 4.08% | 604,488 | 32.08M |
| 291 | BFLY | Butterfly Network, Inc. | 1.78B | 1.94% | 5,846,659 | 102.92M |
| 292 | AAPG | Ascentage Pharma Group International | 1.76B | 3.97% | 4,986 | 82.08M |
| 293 | IMCR | Immunocore Holdings plc | 1.75B | 1.26% | 481,584 | 412.81M |
| 294 | TDOC | Teladoc Health, Inc. | 1.75B | 0.62% | 3,211,616 | 2.51B |
| 295 | ATRC | AtriCure, Inc. | 1.75B | -0.76% | 671,902 | 552.16M |
| 296 | ALMR | Alamar Biosciences, Inc. | 1.74B | 5.14% | 189,977 | 87.16M |
| 297 | TRLV | Trulieve Cannabis Corp. | 1.72B | 2.28% | 345,457 | 1.17B |
| 298 | ZYME | Zymeworks Inc. | 1.72B | 1.22% | 512,933 | 81.26M |
| 299 | SRPT | Sarepta Therapeutics, Inc. | 1.71B | -3.68% | 4,123,319 | 2.18B |
| 300 | HCSG | Healthcare Services Group, Inc. | 1.70B | -0.60% | 772,153 | 1.86B |
| 301 | MPLT | MapLight Therapeutics, Inc. | 1.70B | 4.03% | 557,563 | - |
| 302 | FTRE | Fortrea Holdings Inc. | 1.69B | 1.02% | 1,533,345 | 2.71B |
| 303 | BHC | Bausch Health Companies Inc. | 1.69B | -3.42% | 3,624,442 | 10.53B |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | 1.84% | 205,653 | 923.71M |
| 305 | MLTX | MoonLake Immunotherapeutics | 1.66B | 5.30% | 1,154,674 | - |
| 306 | CMPS | COMPASS Pathways plc | 1.64B | 4.37% | 2,878,936 | - |
| 307 | RXRX | Recursion Pharmaceuticals, Inc. | 1.63B | 6.57% | 14,868,168 | 66.41M |
| 308 | HROW | Harrow, Inc. | 1.63B | -1.66% | 759,891 | 268.68M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.62B | 3.28% | 378,254 | 20.00M |
| 310 | INNV | InnovAge Holding Corp. | 1.61B | 6.86% | 361,601 | 949.17M |
| 311 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 5.04% | 3,518,645 | 66.09M |
| 312 | INVA | Innoviva, Inc. | 1.59B | 1.41% | 606,560 | 420.69M |
| 313 | ANAB | AnaptysBio, Inc. | 1.59B | 6.90% | 1,272,000 | 232.39M |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.59B | 2.09% | 1,264,201 | 314.85M |
| 315 | VIR | Vir Biotechnology, Inc. | 1.59B | 2.06% | 1,731,756 | 65.50M |
| 316 | ENOV | Enovis Corporation | 1.56B | 0.97% | 844,144 | 2.28B |
| 317 | SEPN | Septerna, Inc. | 1.52B | 4.56% | 215,408 | 72.26M |
| 318 | XNCR | Xencor, Inc. | 1.52B | 8.72% | 1,826,707 | 97.36M |
| 319 | INSP | Inspire Medical Systems, Inc. | 1.51B | -1.46% | 638,944 | 915.25M |
| 320 | ARDT | Ardent Health, Inc. | 1.50B | 0.10% | 428,430 | 6.43B |
| 321 | AHCO | AdaptHealth Corp. | 1.49B | 2.09% | 1,736,419 | 3.29B |
| 322 | SVRA | Savara Inc. | 1.48B | 6.38% | 2,862,885 | - |
| 323 | IART | Integra LifeSciences Holdings Corporation | 1.48B | 0.64% | 785,903 | 1.64B |
| 324 | PRGO | Perrigo Company plc | 1.45B | -1.13% | 1,849,363 | 4.18B |
| 325 | PNTG | The Pennant Group, Inc. | 1.44B | 0.78% | 303,055 | 1.02B |
| 326 | BLFS | BioLife Solutions, Inc. | 1.43B | 0.34% | 576,998 | 101.66M |
| 327 | ABSI | Absci Corporation | 1.41B | 1.96% | 3,397,652 | 1.84M |
| 328 | PSNL | Personalis, Inc. | 1.41B | 0.75% | 6,812,302 | 64.52M |
| 329 | PAHC | Phibro Animal Health Corporation | 1.37B | 2.45% | 179,458 | 1.50B |
| 330 | AHG | Akso Health Group | 1.37B | 1.27% | 16,818 | 14.84M |
| 331 | OMDA | Omada Health, Inc. | 1.37B | -3.77% | 907,444 | 283.30M |
| 332 | AKTS | Aktis Oncology, Inc. | 1.36B | 2.80% | 244,603 | 8.28M |
| 333 | NVAX | Novavax, Inc. | 1.33B | 2.47% | 2,530,270 | 596.34M |
| 334 | AMN | AMN Healthcare Services, Inc. | 1.33B | 1.30% | 573,215 | 3.42B |
| 335 | AVBP | ArriVent BioPharma, Inc. | 1.32B | 0.14% | 599,640 | - |
| 336 | TRAX | First Tracks Biotherapeutics, Inc. | 1.30B | 1.36% | 1,070,805 | - |
| 337 | KMTS | Kestra Medical Technologies, Ltd. | 1.30B | -4.30% | 303,108 | 95.13M |
| 338 | AVLN | Avalyn Pharma Inc. | 1.29B | 1.40% | 307,467 | - |
| 339 | IMTX | Immatics N.V. | 1.29B | 1.95% | 157,466 | 43.00M |
| 340 | INBX | Inhibrx Biosciences, Inc. | 1.29B | 4.19% | 136,862 | 1.30M |
| 341 | ATEC | Alphatec Holdings, Inc. | 1.28B | 0.36% | 1,980,599 | 787.08M |
| 342 | CNMD | CONMED Corporation | 1.26B | -3.61% | 611,444 | 1.37B |
| 343 | ARDX | Ardelyx, Inc. | 1.26B | - | 3,795,123 | 427.68M |
| 344 | ALVO | Alvotech | 1.26B | 3.23% | 440,710 | 562.04M |
| 345 | MNKD | MannKind Corporation | 1.25B | 1.76% | 4,403,386 | 360.78M |
| 346 | FBRX | Forte Biosciences, Inc. | 1.24B | 6.82% | 927,508 | - |
| 347 | AZTA | Azenta, Inc. | 1.23B | 1.26% | 557,152 | 596.48M |
| 348 | JBIO | Jade Biosciences, Inc. | 1.22B | 4.37% | 910,234 | - |
| 349 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 2.62% | 664,463 | - |
| 350 | IRMD | IRADIMED CORPORATION | 1.21B | -2.12% | 126,070 | 86.28M |
| 351 | AORT | Artivion, Inc. | 1.21B | -1.69% | 535,362 | 458.69M |
| 352 | STAA | STAAR Surgical Company | 1.21B | 1.25% | 1,870,044 | 290.38M |
| 353 | TNDM | Tandem Diabetes Care, Inc. | 1.21B | -2.76% | 1,733,995 | 1.03B |
| 354 | DRTS | Alpha Tau Medical Ltd. | 1.20B | -1.11% | 839,000 | - |
| 355 | ETON | Eton Pharmaceuticals, Inc. | 1.18B | 5.19% | 652,610 | 86.93M |
| 356 | AVNS | Avanos Medical, Inc. | 1.17B | -0.04% | 388,885 | 715.90M |
| 357 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | 0.87% | 301,579 | 796.33M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.16B | 2.54% | 406,616 | 79.76M |
| 359 | NUTX | Nutex Health Inc. | 1.16B | 4.21% | 114,212 | 879.95M |
| 360 | CAPR | Capricor Therapeutics, Inc. | 1.15B | 1.49% | 2,257,379 | 11.13M |
| 361 | USPH | U.S. Physical Therapy, Inc. | 1.14B | 0.43% | 166,808 | 787.69M |
| 362 | SDGR | Schrödinger, Inc. | 1.13B | 0.67% | 940,842 | 254.91M |
| 363 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 2.19% | 161,516 | - |
| 364 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 3.93% | 1,309,677 | - |
| 365 | QDEL | QuidelOrtho Corporation | 1.12B | -0.90% | 1,274,874 | 2.66B |
| 366 | WVE | Wave Life Sciences Ltd. | 1.11B | 1.05% | 1,451,548 | 71.80M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.11B | 3.20% | 428,047 | - |
| 368 | EYPT | EyePoint, Inc. | 1.09B | 3.08% | 1,585,309 | 7.61M |
| 369 | VOR | Vor Biopharma Inc. | 1.09B | 14.90% | 1,338,600 | - |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | 0.27% | 216,144 | 1.03B |
| 371 | CERT | Certara, Inc. | 1.07B | -1.30% | 2,638,927 | 419.75M |
| 372 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.06B | 2.15% | 2,348,814 | 69.64M |
| 373 | IVA | Inventiva S.A. | 1.06B | 1.47% | 816,755 | 7.94M |
| 374 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | -3.64% | 1,129,879 | 322.02M |
| 375 | CRON | Cronos Group Inc. | 1.05B | - | 785,123 | 159.54M |
| 376 | ANRO | Alto Neuroscience, Inc. | 1.05B | 4.52% | 437,464 | - |
| 377 | GDRX | GoodRx Holdings, Inc. | 1.02B | -3.82% | 879,745 | 787.89M |
| 378 | PCRX | Pacira BioSciences, Inc. | 1.01B | 1.70% | 518,744 | 734.86M |
| 379 | OLMA | Olema Pharmaceuticals, Inc. | 1.01B | 2.11% | 521,481 | - |
| 380 | GMRS | GMR Solutions Inc. | 1.01B | 0.23% | 153,730 | 5.83B |
| 381 | BIOA | BioAge Labs, Inc. | 1.01B | 1.48% | 356,738 | 10.32M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 995.63M | 3.35% | 1,110,602 | 59.00K |
| 383 | BVS | Bioventus Inc. | 992.39M | 2.59% | 447,416 | 576.30M |
| 384 | JANX | Janux Therapeutics, Inc. | 991.61M | 1.31% | 710,895 | 13.73M |
| 385 | KURA | Kura Oncology, Inc. | 966.75M | 1.97% | 1,217,904 | 71.64M |
| 386 | SANA | Sana Biotechnology, Inc. | 947.68M | 0.64% | 2,101,130 | - |
| 387 | PHAR | Pharming Group N.V. | 930.25M | 0.11% | 3,003 | 369.49M |
| 388 | LBRX | LB Pharmaceuticals Inc | 926.54M | 4.56% | 185,463 | - |
| 389 | GERN | Geron Corporation | 923.79M | - | 5,143,963 | 196.12M |
| 390 | REPL | Replimune Group, Inc. | 923.40M | 4.66% | 4,069,996 | - |
| 391 | OPK | OPKO Health, Inc. | 913.66M | 0.83% | 2,167,478 | 581.12M |
| 392 | GLAS | Glass House Brands Inc. | 912.86M | 0.19% | 164,566 | 177.68M |
| 393 | PHAT | Phathom Pharmaceuticals, Inc. | 893.59M | 5.63% | 952,454 | 204.89M |
| 394 | ABUS | Arbutus Biopharma Corporation | 892.87M | 2.49% | 2,217,448 | 191.45M |
| 395 | ANNX | Annexon, Inc. | 883.11M | -3.23% | 2,956,279 | - |
| 396 | INMD | InMode Ltd. | 882.90M | - | 387,930 | 374.64M |
| 397 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 731,175 | 238.37M |
| 398 | TBPH | Theravance Biopharma, Inc. | 872.79M | 0.18% | 847,843 | 109.78M |
| 399 | ODTX | Odyssey Therapeutics, Inc. | 872.34M | 3.64% | 147,080 | 1.06M |
| 400 | AMPH | Amphastar Pharmaceuticals, Inc. | 863.78M | -0.20% | 621,074 | 720.53M |
| 401 | DBVT | DBV Technologies S.A. | 835.25M | -2.40% | 478,937 | 5.04M |
| 402 | SLDB | Solid Biosciences Inc. | 832.88M | 0.12% | 989,855 | - |
| 403 | AVR | Anteris Technologies Global Corp. | 827.39M | 3.28% | 1,357,563 | 1.85M |
| 404 | HSTM | HealthStream, Inc. | 813.35M | -1.73% | 180,933 | 311.78M |
| 405 | TENX | Tenax Therapeutics, Inc. | 803.16M | 0.26% | 1,276,799 | - |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 794.69M | 2.15% | 1,358,584 | 8.37M |
| 407 | BBNX | Beta Bionics, Inc. | 785.18M | -1.12% | 1,095,304 | 110.24M |
| 408 | AURA | Aura Biosciences, Inc. | 775.40M | 3.08% | 307,552 | - |
| 409 | DRUG | Bright Minds Biosciences Inc. | 765.45M | 3.59% | 136,165 | - |
| 410 | MNPR | Monopar Therapeutics Inc. | 760.78M | 7.24% | 247,640 | - |
| 411 | SIBN | SI-BONE, Inc. | 755.71M | -0.47% | 436,903 | 206.22M |
| 412 | DSGN | Design Therapeutics, Inc. | 753.23M | 1.60% | 413,289 | - |
| 413 | CLYM | Climb Bio, Inc. | 750.11M | 7.20% | 1,513,768 | - |
| 414 | CADL | Candel Therapeutics, Inc. | 748.82M | 6.79% | 1,284,137 | - |
| 415 | CTMX | CytomX Therapeutics, Inc. | 744.54M | -2.84% | 5,960,225 | 35.54M |
| 416 | CSTL | Castle Biosciences, Inc. | 743.39M | 2.55% | 326,249 | 339.92M |
| 417 | ZVRA | Zevra Therapeutics, Inc. | 735.98M | 3.49% | 867,049 | 122.29M |
| 418 | FTH | Faeth Therapeutics, Inc. | 731.34M | 0.64% | 616,378 | - |
| 419 | NGNE | Neurogene Inc. | 730.92M | -1.77% | 226,631 | 925.00K |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 727.32M | -0.91% | 456,768 | 299.77M |
| 421 | OCS | Oculis Holding AG | 722.24M | 1.96% | 327,396 | 1.40M |
| 422 | EVO | Evotec SE | 716.68M | 1.01% | 29,929 | 859.03M |
| 423 | SSII | SS Innovations International, Inc. | 716.47M | -4.53% | 40,828 | 48.47M |
| 424 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 698.53M | 3.56% | 429,477 | - |
| 425 | OMER | Omeros Corporation | 689.74M | -1.04% | 1,019,774 | 9.89M |
| 426 | CBIO | Crescent Biopharma, Inc. | 687.63M | 10.56% | 789,675 | 11.88M |
| 427 | IMMX | Immix Biopharma, Inc. | 681.29M | 8.75% | 2,481,351 | - |
| 428 | CBLL | CeriBell, Inc. | 678.79M | -2.93% | 288,843 | 95.07M |
| 429 | SGP | SpyGlass Pharma, Inc. | 677.69M | 1.25% | 111,272 | - |
| 430 | GYRE | Gyre Therapeutics, Inc. | 675.62M | 3.06% | 35,873 | 117.05M |
| 431 | ACHV | Achieve Life Sciences, Inc. | 667.28M | 4.17% | 851,879 | - |
| 432 | BWAY | BrainsWay Ltd. | 661.54M | -2.12% | 127,979 | 56.22M |
| 433 | EVH | Evolent Health, Inc. | 658.01M | -1.35% | 3,158,970 | 1.89B |
| 434 | PHR | Phreesia, Inc. | 655.21M | -0.75% | 584,279 | 495.59M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 643.64M | 1.56% | 1,164,204 | 361.51M |
| 436 | MDXG | MiMedx Group, Inc. | 643.45M | -0.23% | 1,110,940 | 389.42M |
| 437 | CRMD | CorMedix Inc. | 642.52M | 5.27% | 1,038,433 | 400.05M |
| 438 | TCMD | Tactile Systems Technology, Inc. | 641.27M | 0.14% | 166,277 | 343.52M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 638.54M | 4.52% | 4,490,116 | 22.00K |
| 440 | SPRY | ARS Pharmaceuticals, Inc. | 631.57M | -1.24% | 4,881,007 | 98.99M |
| 441 | CERS | Cerus Corporation | 625.15M | -0.95% | 2,849,613 | 216.56M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 618.91M | 2.28% | 146,219 | - |
| 443 | SLBT | SL Science Holding Limited | 607.71M | -4.33% | 62,526 | 3.36M |
| 444 | NVCT | Nuvectis Pharma, Inc. | 601.51M | 5.82% | 198,397 | - |
| 445 | FDMT | 4D Molecular Therapeutics, Inc. | 594.64M | 2.57% | 1,025,541 | 88.24M |
| 446 | CTKB | Cytek Biosciences, Inc. | 590.18M | -0.22% | 790,818 | 204.17M |
| 447 | ANGO | AngioDynamics, Inc. | 587.75M | 3.72% | 602,536 | 320.17M |
| 448 | AGMB | AgomAb Therapeutics NV | 573.25M | -2.84% | 107,667 | - |
| 449 | FLGT | Fulgent Genetics, Inc. | 564.60M | 1.38% | 299,560 | 320.35M |
| 450 | PRME | Prime Medicine, Inc. | 563.53M | 2.30% | 3,751,427 | 4.03M |
| 451 | MYGN | Myriad Genetics, Inc. | 558.19M | -0.17% | 630,679 | 829.00M |
| 452 | RLMD | Relmada Therapeutics, Inc. | 555.92M | 6.00% | 2,667,626 | - |
| 453 | STTK | Shattuck Labs, Inc. | 552.87M | 5.72% | 1,139,127 | 1.00M |
| 454 | ALT | Altimmune, Inc. | 548.42M | 0.36% | 1,984,648 | 36.00K |
| 455 | SOPH | SOPHiA GENETICS SA | 545.32M | 2.69% | 406,155 | 81.18M |
| 456 | TOI | The Oncology Institute, Inc. | 542.91M | -1.27% | 1,696,886 | 545.76M |
| 457 | WEAV | Weave Communications, Inc. | 541.05M | -4.90% | 891,183 | 248.72M |
| 458 | ZURA | Zura Bio Limited | 539.59M | 7.98% | 619,763 | - |
| 459 | EIKN | Eikon Therapeutics, Inc. | 536.51M | 2.69% | 264,722 | - |
| 460 | RGNX | REGENXBIO Inc. | 534.57M | 0.19% | 1,980,710 | 87.82M |
| 461 | ARVN | Arvinas, Inc. | 532.95M | 2.99% | 625,545 | 89.40M |
| 462 | RZLT | Rezolute, Inc. | 531.74M | 14.38% | 1,416,020 | - |
| 463 | VSTM | Verastem, Inc. | 527.24M | 4.35% | 2,532,260 | 49.59M |
| 464 | NPCE | NeuroPace, Inc. | 527.09M | -1.84% | 136,909 | 99.53M |
| 465 | ASMB | Assembly Biosciences, Inc. | 524.56M | 5.63% | 112,042 | 71.10M |
| 466 | ANL | Adlai Nortye Ltd. | 520.00M | 8.51% | 315,133 | 5.00M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 519.67M | 2.73% | 171,502 | - |
| 468 | DNA | Ginkgo Bioworks Holdings, Inc. | 515.41M | 4.50% | 704,070 | 151.40M |
| 469 | SLN | Silence Therapeutics plc | 512.49M | 3.43% | 162,992 | 839.00K |
| 470 | AQST | Aquestive Therapeutics, Inc. | 506.89M | 2.41% | 1,797,138 | 50.27M |
| 471 | TLRY | Tilray Brands, Inc. | 505.76M | 0.24% | 4,070,957 | 858.28M |
| 472 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 473 | HELP | Cybin Inc. | 502.07M | 13.92% | 5,632,231 | - |
| 474 | KIDS | OrthoPediatrics Corp. | 500.60M | -0.15% | 166,178 | 243.30M |
| 475 | CTEV | Claritev Corporation | 489.10M | -4.75% | 65,083 | 978.76M |
| 476 | ARTV | Artiva Biotherapeutics, Inc. | 485.88M | 9.29% | 517,978 | 251.00K |
| 477 | NRC | NRC Health | 484.09M | 0.33% | 80,769 | 138.64M |
| 478 | PROK | ProKidney Corp. | 481.79M | 2.24% | 591,230 | 889.00K |
| 479 | OFIX | Orthofix Medical Inc. | 470.10M | 0.61% | 417,478 | 825.37M |
| 480 | CLPT | ClearPoint Neuro, Inc. | 462.14M | 2.39% | 527,122 | 40.61M |
| 481 | VALN | Valneva SE | 461.30M | 1.86% | 9,349 | 180.25M |
| 482 | CABA | Cabaletta Bio, Inc. | 459.81M | 2.55% | 2,587,950 | - |
| 483 | PRTA | Prothena Corporation plc | 458.09M | 0.92% | 647,645 | 57.94M |
| 484 | VMD | Viemed Healthcare, Inc. | 456.97M | -0.42% | 208,456 | 286.57M |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 454.75M | 3.31% | 882,686 | - |
| 486 | VREX | Varex Imaging Corporation | 451.81M | 0.94% | 302,128 | 857.50M |
| 487 | OVID | Ovid Therapeutics Inc. | 449.80M | 4.56% | 1,779,650 | 7.12M |
| 488 | SRTA | Strata Critical Medical, Inc. | 446.48M | 1.98% | 1,364,379 | 228.58M |
| 489 | EDIT | Editas Medicine, Inc. | 443.50M | 0.35% | 1,146,193 | 38.69M |
| 490 | DCTH | Delcath Systems, Inc. | 442.22M | 1.75% | 278,107 | 90.44M |
| 491 | EVMN | Evommune, Inc. | 440.14M | 5.98% | 433,826 | 10.00M |
| 492 | OCGN | Ocugen, Inc. | 440.08M | -2.26% | 7,690,100 | 4.47M |
| 493 | PBYI | Puma Biotechnology, Inc. | 436.72M | 3.37% | 444,125 | 227.18M |
| 494 | SGMT | Sagimet Biosciences Inc. | 436.59M | -1.26% | 758,693 | - |
| 495 | PACB | Pacific Biosciences of California, Inc. | 434.84M | 2.94% | 7,438,666 | 160.03M |
| 496 | CYH | Community Health Systems, Inc. | 434.81M | 2.88% | 1,200,831 | 12.29B |
| 497 | SI | Shoulder Innovations, Inc. | 431.36M | -0.91% | 111,106 | 53.89M |
| 498 | CCRN | Cross Country Healthcare, Inc. | 428.06M | - | - | 1.00B |
| 499 | CCCC | C4 Therapeutics, Inc. | 423.47M | 6.98% | 3,196,417 | 34.86M |
| 500 | NNNN | Anbio Biotechnology | 417.84M | - | 51,309 | 8.65M |